Scientists dig into old tumor samples to outsmart parathyroid cancer
NCT ID NCT03039439
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study examines stored tumor tissue and blood samples from 310 people with parathyroid tumors. Researchers aim to find molecular and genetic markers that can better distinguish between benign and cancerous tumors. The goal is to reduce misdiagnosis, unnecessary surgery, and stress, while also identifying genes that could be targeted by new drugs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more accurate diagnosis of parathyroid tumors and identify new drug targets for treatment.
- What could go wrong
- This is an observational study using stored samples, so it won't directly test any treatment. Results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARATHYROID GLAND ADENOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new infrared camera help surgeons spot nerves and bile ducts?
- Is surgery better than watching for seniors with high calcium?
- Scientists probe parathyroid tumors for clues to better surgery
- New imaging technique could help surgeons spot hidden parathyroid tumors
- New bone scanners could predict fractures better than current methods
- Parathyroid surgery may lower blood pressure hormone, study hopes to find out